Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$38.62 - $72.18 $1.74 Million - $3.25 Million
-45,000 Reduced 99.56%
200 $12,000
Q3 2023

Nov 14, 2023

BUY
$45.39 - $59.0 $9,078 - $11,800
200 Added 0.44%
45,200 $2.05 Million
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $634,662 - $989,442
-14,600 Reduced 24.5%
45,000 $2.53 Million
Q1 2023

May 15, 2023

BUY
$41.0 - $56.12 $1.83 Million - $2.51 Million
44,700 Added 300.0%
59,600 $2.7 Million
Q4 2022

Feb 14, 2023

SELL
$39.19 - $65.67 $58,785 - $98,505
-1,500 Reduced 9.15%
14,900 $605,000
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $24,440 - $33,512
400 Added 2.5%
16,400 $1.07 Million
Q2 2022

Aug 15, 2022

SELL
$43.23 - $73.83 $648,450 - $1.11 Million
-15,000 Reduced 48.39%
16,000 $973,000
Q1 2022

May 16, 2022

SELL
$53.19 - $79.24 $4.26 Million - $6.34 Million
-80,000 Reduced 72.07%
31,000 $1.95 Million
Q4 2021

Feb 14, 2022

SELL
$70.09 - $111.29 $7.18 Million - $11.4 Million
-102,400 Reduced 47.99%
111,000 $8.41 Million
Q3 2021

Nov 15, 2021

BUY
$110.2 - $156.64 $3.69 Million - $5.25 Million
33,500 Added 18.62%
213,400 $23.9 Million
Q2 2021

Aug 16, 2021

BUY
$100.84 - $161.89 $10.6 Million - $17 Million
104,900 Added 139.87%
179,900 $29.1 Million
Q1 2021

May 14, 2021

BUY
$110.72 - $210.04 $8.3 Million - $15.8 Million
75,000 New
75,000 $9.14 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.